Telix Pharmaceuticals Limited Adjustments For Decrease Increase In Trade And Other Receivables
Telix Pharmaceuticals Limited (TLPPF) reported Adjustments For Decrease Increase In Trade And Other Receivables of -$20.46 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables · last filed 2026-02-20
AUD
| Period end | Adjustments For Decrease Increase In Trade And Other Receivables 12 month |
|---|---|
| 2024-12-31 | -57.08M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | -27.38M AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | -19.93M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Adjustments For Decrease Increase In Trade And Other Receivables 12 month |
|---|---|
| 2025-12-31 | -$20.46M 20-F · filed 2026-02-20 |
| 2024-12-31 | -$37.49M 20-F · filed 2026-02-20 |
| 2023-12-31 | -$18.62M 20-F · filed 2026-02-20 |